TASLY(600535) 证券之星·2025-03-27 13:00Group 1 - The core point of the announcement is the completion of the transfer of shares from Tianjin Tianshili Group and its concerted actors to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. and Guoxin Investment Co., Ltd., resulting in a change of control of Tianshili Pharmaceutical Group [1][2] - Tianjin Tianshili Group and its concerted actors transferred a total of 418,306,002 shares, representing 28% of the total share capital of Tianshili, to China Resources Sanjiu [1][5] - Guoxin Investment acquired 74,697,501 shares, accounting for 5% of the total share capital, as part of the agreement [2][5] Group 2 - Following the completion of the share transfer, the controlling shareholder changed from Tianjin Tianshili Group to China Resources Sanjiu, with the actual controller now being China Resources Limited [2][5] - After the transfer, Tianjin Tianshili Group and its concerted actors hold a total of 261,452,489 shares, which is 17.5008% of the total share capital [4][5] - Tianshili Group has committed to relinquishing voting rights corresponding to 5% of its shares, ensuring that the voting rights controlled do not exceed 12.5008% of the total issued shares [4][5]